BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.01B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$623M |
| 3 |
State Street SPDR S&P Biotech ETF
XBI
|
+$175M |
| 4 |
Merck
MRK
|
+$138M |
| 5 |
Canadian Pacific Kansas City
CP
|
+$125M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$949M |
| 2 |
Bank of America
BAC
|
+$275M |
| 3 |
VanEck Gold Miners ETF
GDX
|
+$208M |
| 4 |
Canadian National Railway
CNI
|
+$154M |
| 5 |
iShares US Real Estate ETF
IYR
|
+$146M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.39% |
| 2 | Financials | 8.44% |
| 3 | Consumer Discretionary | 6.01% |
| 4 | Industrials | 6% |
| 5 | Healthcare | 5.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LDL
2551
DELISTED
Lydall, Inc.
LDL
| $41.8K | ﹤0.01% |
1,415
+1,011
| +250% | +$29.3K |
|
2552
Columbus McKinnon
CMCO
$543M
| $41.7K | ﹤0.01% |
1,669
+1,202
| +257% | +$29.8K |
|
2553
Mercury Systems
MRCY
$6.53B
| $41.7K | ﹤0.01% |
2,845
+2,064
| +264% | +$30K |
|
|
RVNC
2554
DELISTED
Revance Therapeutics, Inc.
RVNC
| $41.6K | ﹤0.01% |
1,302
+1,106
| +564% | +$28.4K |
|
2555
StoneX
SNEX
$7.91B
| $41.6K | ﹤0.01% |
6,333
+4,495
| +245% | +$30.1K |
|
|
SRNE
2556
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $41.6K | ﹤0.01% |
+2,360
| New | +$30.3K |
|
|
RALY
2557
DELISTED
RALLY SOFTWARE DEV CORP
RALY
| $41.5K | ﹤0.01% |
2,133
+1,557
| +270% | +$25.7K |
|
2558
UNIFI
UFI
$120M
| $41.4K | ﹤0.01% |
1,237
+891
| +258% | +$30.4K |
|
|
LHCG
2559
DELISTED
LHC Group LLC
LHCG
| $41.4K | ﹤0.01% |
1,083
+789
| +268% | +$27.9K |
|
2560
Banc of California
BANC
$3.14B
| $41.4K | ﹤0.01% |
3,012
+2,238
| +289% | +$29.3K |
|
2561
World Acceptance Corp
WRLD
$895M
| $41.4K | ﹤0.01% |
673
+489
| +266% | +$38.9K |
|
|
RLD
2562
DELISTED
REALD INC COM STK
RLD
| $41.4K | ﹤0.01% |
3,356
+2,412
| +256% | +$30.2K |
|
|
TUES
2563
DELISTED
Tuesday Morning Corp
TUES
| $41.3K | ﹤0.01% |
3,665
+2,643
| +259% | +$38.4K |
|
2564
Cerus
CERS
$566M
| $41.2K | ﹤0.01% |
7,934
+6,291
| +383% | +$29.8K |
|
2565
Hyatt Hotels
H
$17.2B
| $41.1K | ﹤0.01% |
725
-183
| -20% | -$10.6K |
|
|
TNGO
2566
DELISTED
Tangoe, Inc.
TNGO
| $40.8K | ﹤0.01% |
3,246
+2,329
| +254% | +$31.3K |
|
|
MITT
2567
TPG Mortgage Investment Trust
MITT
$213M
| $40.8K | ﹤0.01% |
787
+563
| +251% | +$31.7K |
|
2568
ANI Pharmaceuticals
ANIP
$1.71B
| $40.6K | ﹤0.01% |
655
+498
| +317% | +$29.6K |
|
2569
Matrix Service
MTRX
$331M
| $40.6K | ﹤0.01% |
2,223
+1,597
| +255% | +$31.3K |
|
2570
NN Inc
NNBR
$303M
| $40.6K | ﹤0.01% |
1,592
+1,178
| +285% | +$31K |
|
2571
Installed Building Products
IBP
$6.56B
| $40.5K | ﹤0.01% |
1,656
+1,450
| +704% | +$32.7K |
|
|
SCLN
2572
DELISTED
Sciclone Pharmaceuticals Inc
SCLN
| $40.5K | ﹤0.01% |
4,126
+2,898
| +236% | +$26.4K |
|
|
HTO
2573
H2O America
HTO
$2.66B
| $40.4K | ﹤0.01% |
1,317
+951
| +260% | +$28.7K |
|
2574
Patrick Industries
PATK
$2.75B
| $40.3K | ﹤0.01% |
2,383
+1,738
| +269% | +$30.4K |
|
2575
Anika Therapeutics
ANIK
$285M
| $40.2K | ﹤0.01% |
1,217
+866
| +247% | +$30.9K |
|
Similar funds
BNP Paribas Financial Markets's Q2 2015 Portfolio in Review
As of Q2 2015, BNP Paribas Financial Markets held 3,782 positions worth $35.8B, down 0.81% from $36.1B the previous quarter. Its ten largest holdings account for 42% of the portfolio.
BNP Paribas Financial Markets's Q2 2015 filing shows 210 new, 2,320 increased, 874 reduced and 237 closed positions. Its largest new stake was Vanguard S&P 500 ETF: 300,000 shares worth $56.7M. The largest sale was Apple, an estimated $949M.
By sector, the portfolio is most concentrated in Technology at 10% of assets, down from 14% a quarter earlier, followed by Financials and Consumer Discretionary.
- BNP Paribas Financial Markets's largest Q2 2015 buy was Vanguard S&P 500 ETF: 300,000 shares worth $56.7M.
- BNP Paribas Financial Markets added most to State Street SPDR S&P 500 ETF Trust in Q2 2015, an estimated $2.01B increase.
- BNP Paribas Financial Markets's biggest Q2 2015 reduction was Apple, cutting an estimated $949M.
- BNP Paribas Financial Markets fully exited Allergan plc in Q2 2015, selling an estimated $55.7M.
- BNP Paribas Financial Markets's ten largest holdings make up 42% of its $35.8B portfolio in Q2 2015.
- BNP Paribas Financial Markets opened 210 new positions and closed 237 in Q2 2015.
- BNP Paribas Financial Markets's portfolio value fell 0.81% quarter-over-quarter to $35.8B.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2015, filed 14 Aug 2015.